Alphabet (NASDAQ:GOOG – Get Free Report) had its target price lifted by JPMorgan Chase & Co. from $420.00 to $425.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the information services provider’s stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 22.89% from the […]

Synopsys (NASDAQ:SNPS – Free Report) had its price objective raised by Needham & Company LLC from $580.00 to $620.00 in a research note published on Monday, Marketbeat.com reports. The brokerage currently has a buy rating on the semiconductor company’s stock. Other research analysts also recently issued reports about the stock. Weiss Ratings downgraded shares of […]

F5 (NASDAQ:FFIV – Free Report) had its price objective lifted by Royal Bank Of Canada from $508.00 to $525.00 in a report published on Monday morning, Marketbeat Ratings reports. Royal Bank Of Canada currently has an outperform rating on the network technology company’s stock. Other analysts also recently issued reports about the stock. Weiss Ratings […]

Atlassian (NASDAQ:TEAM – Free Report) had its price objective hoisted by Royal Bank Of Canada from $215.00 to $235.00 in a report published on Monday morning, Marketbeat reports. They currently have an outperform rating on the technology company’s stock. TEAM has been the subject of several other reports. KeyCorp boosted their price target on Atlassian […]

Amgen (NASDAQ:AMGN – Free Report) had its price objective increased by UBS Group from $430.00 to $470.00 in a research note released on Friday,Benzinga reports. They currently have a buy rating on the medical research company’s stock. A number of other research firms also recently issued reports on AMGN. Wall Street Zen upgraded Amgen from […]

Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective raised by Royal Bank Of Canada from $123.00 to $126.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have a sector perform rating on the biopharmaceutical company’s stock. GILD has been the subject of a number of other reports. Needham […]

Zscaler (NASDAQ:ZS – Free Report) had its target price raised by Morgan Stanley from $165.00 to $185.00 in a report issued on Wednesday morning, MarketBeat Ratings reports. The brokerage currently has an equal weight rating on the stock. Other analysts also recently issued research reports about the company. Citigroup raised their price objective on Zscaler […]

Genmab A/S (NASDAQ:GMAB – Free Report) had its price target increased by Truist Financial from $40.00 to $45.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other brokerages have also issued reports on GMAB. HC Wainwright boosted their price target on shares of Genmab […]

OmniAb (NASDAQ:OABI – Free Report) had its price target hoisted by Leerink Partners from $10.00 to $12.00 in a research note released on Wednesday,Benzinga reports. The firm currently has an outperform rating on the stock. Several other brokerages also recently issued reports on OABI. HC Wainwright reissued a “buy” rating and issued a $11.00 price […]

Amgen (NASDAQ:AMGN – Free Report) had its price objective raised by Truist Financial from $362.00 to $380.00 in a research report report published on Wednesday morning, Marketbeat.com reports. The brokerage currently has a hold rating on the medical research company’s stock. A number of other brokerages have also recently commented on AMGN. TD Cowen increased […]

Zscaler (NASDAQ:ZS – Free Report) had its target price lifted by Cantor Fitzgerald from $225.00 to $275.00 in a report issued on Wednesday morning, MarketBeat Ratings reports. The firm currently has an overweight rating on the stock. Other equities research analysts have also issued research reports about the company. Guggenheim reiterated a “buy” rating on […]

Intel (NASDAQ:INTC – Free Report) had its target price boosted by Mizuho from $92.00 to $114.00 in a research report sent to investors on Tuesday morning, MarketBeat.com reports. The brokerage currently has a neutral rating on the chip maker’s stock. Several other brokerages also recently commented on INTC. Wells Fargo & Company increased their price […]

Shopify (NASDAQ:SHOP – Free Report) (TSE:SHOP) had its price objective raised by JPMorgan Chase & Co. from $185.00 to $200.00 in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has an overweight rating on the software maker’s stock. Several other equities analysts also recently weighed in on the company. DA Davidson set […]

XP (NASDAQ:XP – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $26.00 to $38.00 in a report published on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the stock. A number of other brokerages have also issued reports on XP. Itau BBA Securities upgraded XP from a […]

SailPoint (NASDAQ:SAIL – Get Free Report) had its price target increased by investment analysts at Robert W. Baird from $22.00 to $25.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Robert W. Baird’s price objective would indicate a potential upside of 27.68% from the […]

Elmet Group (NASDAQ:ELMT – Get Free Report) had its price objective upped by research analysts at Needham & Company LLC from $25.00 to $28.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s target price points to […]

Vaxcyte (NASDAQ:PCVX – Free Report) had its target price upped by Needham & Company LLC from $110.00 to $122.00 in a research report report published on Monday morning, MarketBeat reports. They currently have a buy rating on the stock. A number of other equities research analysts have also weighed in on the stock. Bank of […]

Microsoft (NASDAQ:MSFT – Free Report) had its price target lifted by Piper Sandler from $550.00 to $610.00 in a research report sent to investors on Wednesday, Marketbeat reports. They currently have an overweight rating on the software giant’s stock. Other equities analysts also recently issued research reports about the company. Truist Financial restated a “buy” […]